PRODUCTS
‹
›
‹
›
Product name: lenvatini Mesylate
CAS No.: 857890-39-2
MF: C22H23ClN4O7S
M.W.: 522.95862g/mol
Capacity: 100KG/M
Usage: Cancer/tumor
INQUIRY NOW
■ Description
Description：Levatinib mesylate is the mesylate of levatinib, which is a multi-target tyrosine kinase inhibitor that may act on various cancers. Lenvatini Mesylate (E7080) is a synthetic and orally active inhibitor of tyrosine kinase, which can inhibit vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), and platelet derived growth factor receptor (PDGFR) α)， Stem cell factor receptors (Kit (c-Kit)) are rearranged during transfection (RET (c-RET)). Levatinib mesylate has potential anti-tumor activity.
■ Message
Leave A Message
If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.